AR
DRNA

Advisory Research’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Advisory Research’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,135
Closed -$333K – 358
2020
Q1 		$333K Sell
18,135
-3,516
-16% -$64.6K 0.02% 234
2019
Q4 		$477K Buy
+21,651
New +$477K 0.02% 244